Patient Access Solutions Inc. to Present at National Investment
Banking Association (NIBA) 141st Investment Conference
Commack, NY, June 20, 2017 Patient Access Solutions, Inc.
(PASO), a provider of healthcare/financial processing and
management solutions for the healthcare, and dental industries,
proudly announces that it will be presenting at the National
Investment Banking Association (NIBA) 141st Investment Conference
on June 27, 2017 in New York City.
Bruce Weitzberg, CEO of Patient Access Solutions will be giving
the presentation along with Dr. Michael Gruttadauria, Clinical
Director for The CIIT Center. Both will be meeting with investment
bankers for one on one meetings throughout the conference.
Bruce Weitzberg, CEO stated, We are excited to participate at
NIBA and share our companys passion and progress, as the CIIT
Center grows.
About Patient Access Solutions Inc.(www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare
Solutions company which has created a formidable array of
technology, and management resources and allies to enable it to
become an agent of radical change in what has traditionally been a
slowly evolving healthcare environment. For more information about
the services and products of Patient Access Solutions, please visit
our website at www.pashealth.com.
About the CIIT Center (www.theciitcenter.com)
The CIIT Center, specializing in the treatment of children with
autism spectrum disorder, as
well as adults with traumatic brain injury such as
a concussion, and chronic conditions like migraine, post-traumatic stress
disorder, autoimmune diseases and so much more. The
Center occupies 12,500-square feet, in a street level office
building located right off two major highways in Plainview, NY. The
progressive center provides great efficiency and convenience in how
we serve our patients. The goal is to create integrated,
personalized treatment programs where the patient and staff work in
unison to identify the underlying health conditions causing the
issues, as opposed to just treating the symptoms.
About National Investment Banking Association (NIBA)
Since 1982, National Investment Banking Association (NIBA) has
been a not-for-profit association comprised of micro-cap and
small-cap professionals encompassing Broker Dealers, Investment
Bankers, RIAs, Private Equity Groups, Family Offices, Boutique
Corp. Finance, Specialized Investment Brokerages, Venture Capital
Groups, Fund Managers, Investors, etc. NIBA provides unique
opportunities for investment professionals to make valuable
industry connections while gaining new perspectives on critical
market challenges, issues and trends redefining todays dynamic and
ever-evolving capital markets.
National Investment Banking Association continues to be the
premier forum for quality micro-cap/small-cap companies seeking
access and exposure to the financial community. NIBAs must-attend
events showcase private and public companies actively seeking
access to the financial industry. Companies first present formally
to hundreds and then have the opportunity to meet privately and
have in-depth discussions with interested parties.
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the companies,
are forward-looking statements that involve risks and
uncertainties. There can be no assurance that such statements will
prove to be accurate and actual results and future events could
differ materially from those anticipated in such statements.
Factors that could cause actual results to differ materially from
those in the forward-looking statements include, among other
things, the following: general economic and business conditions;
competition; unexpected changes in technologies and technological
advances; ability to commercialize and manufacture products;
results of experimental studies; research and development
activities; changes in, or failure to comply with, governmental
regulations; and the ability to obtain adequate financing in the
future. This information is qualified in its entirety by cautionary
statements and risk factors disclosure contained in certain of
Patient Access Solutions Inc. Securities and Exchange Commission
filings available at http://www.sec.gov.
Investor Information
631-241-9404
